Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

J. Douglas Rizzo MD, MS

J. Douglas Rizzo MD, MS profile photo picture

Director, Center Associate Director, Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

Member of the Cancer Center
Member of the Center for International Blood and Marrow Transplant Research (CIBMTR)

View Curriculum Vitae

Research Experience

  • Hematopoietic Stem Cell Transplantation
  • Neoplasms, Second Primary
  • Quality of Life
  • Survival Analysis
  • Treatment Outcome

    • Publications (188)

  • Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018. (Valcarcel B, Schonfeld SJ, Meyer CL, Brunson A, Cooley JJP, Abrahão R, Wun T, Auletta JJ, Gadalla SM, Engels E, Albert PS, Spellman SR, Rizzo JD, Shaw BE, Muffly L, Keegan THM, Morton LM) Transplant Cell Ther 2024 Feb;30(2):239.e1-239.e11 PMID: 37981238 PMCID: PMC10872486 SCOPUS ID: 2-s2.0-85180597524 11/20/2023    
  • Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis. (Cho C, Devlin S, Maloy M, Horowitz MM, Logan B, Rizzo JD, Giralt SA, Perales MA) Bone Marrow Transplant 2023 Oct;58(10):1089-1095 PMID: 37422574 PMCID: PMC10592419 SCOPUS ID: 2-s2.0-85164194423 07/09/2023    
  • Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. (Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez WS, Phelan R, Riches ML, Rizzo JD, Saber W, Spellman SR, Stefanski HE, Steinert P, Tuschl E, Yusuf R, Zhang MJ, Shaw BE) Transplant Cell Ther 2023 Jun;29(6):346.e1-346.e10 PMID: 36924931 PMCID: PMC10239334 SCOPUS ID: 2-s2.0-85153327578 03/17/2023       12 Citations
  • Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). (Saccardi R, Putter H, Eikema DJ, Busto MP, McGrath E, Middelkoop B, Adams G, Atlija M, Ayuk FA, Baldomero H, Beguin Y, de la Cámara R, Cedillo Á, Balari AMS, Chabannon C, Corbacioglu S, Dolstra H, Duarte RF, Dulery R, Greco R, Gusi A, Hamad N, Kenyon M, Kröger N, Labopin M, Lee J, Ljungman P, Manson L, Mensil F, Milpied N, Mohty M, Oldani E, Orchard K, Passweg J, Pearce R, de Latour RP, Poirel HA, Rintala T, Rizzo JD, Ruggeri A, Sanchez-Martinez C, Sanchez-Guijo F, Sánchez-Ortega I, Trnková M, Ferreiras DV, Wilcox L, de Wreede LC, Snowden JA) Bone Marrow Transplant 2023 Jun;58(6):659-666 PMID: 36894635 PMCID: PMC9995719 SCOPUS ID: 2-s2.0-85149466633 03/10/2023       2 Citations
  • Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Transplant Cell Ther 2022 Oct;28(10):717 PMID: 36202527 SCOPUS ID: 2-s2.0-85101258094 10/07/2022    
  • Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplant Cell Ther 2022 Oct;28(10):715-716 PMID: 36202526 SCOPUS ID: 2-s2.0-85108559179 10/07/2022       1 Citation
  • Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885, (S1083879120304146), (10.1016/j.bbmt.2020.07.005)] (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Transplantation and Cellular Therapy October 2022;28(10):717 SCOPUS ID: 2-s2.0-85101258094 10/01/2022    
  • Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)] (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplantation and Cellular Therapy October 2022;28(10):715-716 SCOPUS ID: 2-s2.0-85108559179 10/01/2022       1 Citation
  • Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. (Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Mattila D, Mussetter A, Bruzauskas R, Chen M, Leckrone E, Myers J, Mau LW, Rizzo JD, Saber W, Horowitz M, Lee SJ, Burns LJ, Shaw B) Transplant Cell Ther 2022 Feb;28(2):112.e1-112.e9 PMID: 34757219 PMCID: PMC8915447 SCOPUS ID: 2-s2.0-85121127060 11/11/2021       4 Citations
  • COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum. (Wingard JR, Ahn KW, Dandoy C, Perales MA, Wood WA, Logan B, Riches M, Rizzo JD) Transplant Cell Ther 2021 Jul;27(7):533-539 PMID: 33895401 PMCID: PMC8061634 SCOPUS ID: 2-s2.0-85107113196 04/26/2021       1 Citation
  • The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill. (Knight JM, Costanzo ES, Singh S, Yin Z, Szabo A, Pawar DS, Hillard CJ, Rizzo JD, D'Souza A, Pasquini M, Coe CL, Irwin MR, Raison CL, Drobyski WR) Transl Psychiatry 2021 Jan 18;11(1):58 PMID: 33462203 PMCID: PMC7812704 SCOPUS ID: 2-s2.0-85100097244 01/20/2021       36 Citations
  • Screening and prevention guidelines for hematopoietic cell transplant survivors (Bhatt NS, Rizzo JD, Majhail NS) Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant: Second Edition 1 January 2021:80-91 SCOPUS ID: 2-s2.0-85111047222 01/01/2021       1 Citation
  • Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States. (Hong S, Brazauskas R, Hebert KM, Ganguly S, Abdel-Azim H, Diaz MA, Beattie S, Ciurea SO, Szwajcer D, Badawy SM, Gratwohl AA, LeMaistre C, Aljurf MDSM, Olsson RF, Bhatt NS, Farhadfar N, Yared JA, Yoshimi A, Seo S, Gergis U, Beitinjaneh AM, Sharma A, Lazarus H, Law J, Ulrickson M, Hashem H, Schoemans H, Cerny J, Rizzieri D, Savani BN, Kamble RT, Shaw BE, Khera N, Wood WA, Hashmi S, Hahn T, Lee SJ, Rizzo JD, Majhail NS, Saber W) Cancer 2021 Feb 15;127(4):609-618 PMID: 33085090 PMCID: PMC7855526 SCOPUS ID: 2-s2.0-85092920705 10/22/2020       11 Citations
  • Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2020 Oct;26(10):1876-1885 PMID: 32653622 PMCID: PMC7571859 SCOPUS ID: 2-s2.0-85089134303 07/13/2020       4 Citations
  • Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Aug;26(8):e177-e182 PMID: 32438042 PMCID: PMC7404814 SCOPUS ID: 2-s2.0-85085969206 05/22/2020       306 Citations
  • Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. (Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):e161-e166 PMID: 32389803 PMCID: PMC7206419 SCOPUS ID: 2-s2.0-85084668943 05/12/2020       38 Citations
  • Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. (Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW) Blood Adv 2020 Feb 11;4(3):467-476 PMID: 32027744 PMCID: PMC7013267 SCOPUS ID: 2-s2.0-85082178004 02/07/2020       36 Citations
  • Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study. (Atallah E, Logan B, Chen M, Cutler C, Deeg J, Jacoby M, Champlin R, Nishihori T, Confer D, Gajewski J, Farnia S, Greenberg P, Warlick E, Weisdorf D, Saber W, Horowitz MM, Rizzo JD) JAMA Oncol 2020 Apr 01;6(4):486-493 PMID: 31830234 PMCID: PMC6990739 SCOPUS ID: 2-s2.0-85076620276 12/13/2019       37 Citations
  • Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia. (Knight JM, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Verneris MR, Arevalo JMG, Cole SW) JNCI Cancer Spectr 2019 Dec;3(4):pkz073 PMID: 31763620 PMCID: PMC6859844 SCOPUS ID: 2-s2.0-85085522039 11/26/2019       18 Citations
  • Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). (Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D, Poirel HA, Ayuk F, Beguin Y, Bonifazi F, Gratwohl A, Milpied N, Moore J, Passweg J, Rizzo JD, Spellman SR, Sierra J, Solano C, Sanchez-Guijo F, Worel N, Gusi A, Adams G, Balan T, Baldomero H, Macq G, Marry E, Mesnil F, Oldani E, Pearce R, Perry J, Raus N, Schanz U, Tran S, Wilcox L, Basak GW, Chabannon C, Corbacioglu S, Dolstra H, Kuball J, Mohty M, Lankester A, Montoto S, Nagler A, Styczynski J, Yakoub-Agha I, de Latour RP, Kroeger N, Brand R, de Wreede LC, van Zwet E, Putter H) Bone Marrow Transplant 2020 Apr;55(4):838-839 PMID: 31754251 PMCID: PMC7609270 SCOPUS ID: 2-s2.0-85082751051 11/23/2019       1 Citation
  • Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. (Majhail NS, Mau LW, Chitphakdithai P, Denzen EM, Joffe S, Lee SJ, LeMaistre CF, Loberiza F, Parsons SK, Repaczki-Jones R, Robinett P, Douglas Rizzo J, Murphy E, Logan B, Le-Rademacher J) Bone Marrow Transplant 2020 May;55(5):906-917 PMID: 31740767 PMCID: PMC7202970 SCOPUS ID: 2-s2.0-85075369259 11/20/2019       32 Citations
  • Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). (Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D, Poirel HA, Ayuk F, Beguin Y, Bonifazi F, Gratwohl A, Milpied N, Moore J, Passweg J, Rizzo JD, Spellman SR, Sierra J, Solano C, Sanchez-Guijo F, Worel N, Gusi A, Adams G, Balan T, Baldomero H, Macq G, Marry E, Mesnil F, Oldani E, Pearce R, Perry J, Raus N, Schanz U, Tran S, Wilcox L, Basak GW, Chabannon C, Corbacioglu S, Dolstra H, Kuball J, Mohty M, Lankester A, Montoto S, Nagler A, Styczynski J, Yakoub-Agha I, de Latour RP, Kroeger N, Brand R, de Wreede LC, van Zwet E, Putter H) Bone Marrow Transplant 2020 Apr;55(4):681-694 PMID: 31636397 PMCID: PMC7113189 SCOPUS ID: 2-s2.0-85074598920 10/23/2019       36 Citations
  • Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE) Biol Blood Marrow Transplant 2019 May;25(5):955-964 PMID: 30605731 PMCID: PMC6511296 SCOPUS ID: 2-s2.0-85061429566 01/04/2019       6 Citations
  • Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. (Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M) Biol Blood Marrow Transplant 2019 Apr;25(4):827-833 PMID: 30572109 SCOPUS ID: 2-s2.0-85059680507 12/21/2018       21 Citations
  • Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. (Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2019 Apr;25(4):699-711 PMID: 30423480 PMCID: PMC6453753 SCOPUS ID: 2-s2.0-85058455309 11/14/2018       10 Citations
  • Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE) Haematologica 2019 Apr;104(4):844-854 PMID: 30381298 PMCID: PMC6442962 SCOPUS ID: 2-s2.0-85064008651 11/02/2018       11 Citations
  • Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation. (Denzen EM, Preussler JM, Murphy EA, Baker KS, Burns LJ, Foster J, Idossa L, Moore HK, Payton TJ, Haven D, Jahagirdar B, Kamani N, Rizzo JD, Salazar L, Schatz BA, Syrjala KL, Wingard JR, Majhail NS) Biol Blood Marrow Transplant 2019 Mar;25(3):562-569 PMID: 30315940 PMCID: PMC6445667 SCOPUS ID: 2-s2.0-85056318658 10/14/2018       14 Citations
  • Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. (Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK) Leuk Res 2018 Nov;74:130-136 PMID: 30055822 PMCID: PMC6219911 SCOPUS ID: 2-s2.0-85050340275 07/30/2018       40 Citations
  • Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation. (Bhatt NS, Brazauskas R, Tecca HR, Vogel J, Mattila D, Lee SJ, Horowitz MM, Rizzo JD, Shaw BE) J Pediatr Hematol Oncol 2019 Apr;41(3):233-237 PMID: 29923857 PMCID: PMC6301126 SCOPUS ID: 2-s2.0-85049213444 06/21/2018       6 Citations
  • Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. (Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD) BMC Cancer 2018 May 24;18(1):593 PMID: 29793446 PMCID: PMC5968588 SCOPUS ID: 2-s2.0-85047544800 05/26/2018       27 Citations
  • Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. (Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, Hari PN, Chhabra S) Biol Blood Marrow Transplant 2018 Aug;24(8):1664-1670 PMID: 29680516 SCOPUS ID: 2-s2.0-85047194888 04/24/2018       31 Citations
  • ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. (Hashmi SK, Lee SJ, Savani BN, Burns L, Wingard JR, Perales MA, Palmer J, Chow E, Meyer E, Marks D, Mohty M, Inamoto Y, Rodriguez C, Nagler A, Sauter C, Komanduri KV, Pidala J, Hamadani M, Johnston L, Shah N, Shaughnessy P, Hamilton BK, Majhail N, Kharfan-Dabaja MA, Schriber J, DeFilipp Z, Tarlock KG, Fanning S, Curtin P, Rizzo JD, Carpenter PA) Biol Blood Marrow Transplant 2018 Jun;24(6):1119-1124 PMID: 29608957 SCOPUS ID: 2-s2.0-85046667868 04/03/2018       30 Citations
  • Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. (D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE) Bone Marrow Transplant 2018 Aug;53(8):1079-1082 PMID: 29515251 PMCID: PMC6098949 SCOPUS ID: 2-s2.0-85042917359 03/09/2018       7 Citations
  • Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease. (Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M) Haematologica 2018 Apr;103(4):717-727 PMID: 29351985 PMCID: PMC5865423 SCOPUS ID: 2-s2.0-85044420638 01/21/2018       36 Citations
  • Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. (Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD) Cancer 2017 Dec 01;123(23):4687-4700 PMID: 28817182 PMCID: PMC5693638 SCOPUS ID: 2-s2.0-85034085598 08/18/2017       45 Citations
  • Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. (Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR) Biol Blood Marrow Transplant 2017 Nov;23(11):1955-1960 PMID: 28757436 SCOPUS ID: 2-s2.0-85028446880 08/02/2017       19 Citations
  • Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. (Jerkins JH, Hamadani M, Zook F, Epperla N, Shaw BE, Saber W, Rizzo JD, Pasquini M, Chhabra S, Drobyski WR, Hari PN, Shah NN) Am J Hematol 2017 Oct;92(10):E610-E611 PMID: 28699171 SCOPUS ID: 2-s2.0-85026445343 07/13/2017       7 Citations
  • Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. (Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M) Biol Blood Marrow Transplant 2017 Aug;23(8):1295-1302 PMID: 28412518 SCOPUS ID: 2-s2.0-85019639994 04/17/2017       8 Citations
  • Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. (Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, Rizzo JD, Theil K, Wang SA, Smith AT, Rumble RB, Thomas NE, Vardiman JW) Arch Pathol Lab Med 2017 Oct;141(10):1342-1393 PMID: 28225303 SCOPUS ID: 2-s2.0-85021786349 02/23/2017       77 Citations
  • Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). (Wingard JR, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight JM, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee SJ) Biol Blood Marrow Transplant 2017 Jan;23(1):161-164 PMID: 27742574 PMCID: PMC5182134 SCOPUS ID: 2-s2.0-85006489235 10/16/2016       9 Citations
  • National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report. (Hashmi SK, Bredeson C, Duarte RF, Farnia S, Ferrey S, Fitzhugh C, Flowers MED, Gajewski J, Gastineau D, Greenwald M, Jagasia M, Martin P, Rizzo JD, Schmit-Pokorny K, Majhail NS) Biol Blood Marrow Transplant 2017 May;23(5):717-725 PMID: 27713091 PMCID: PMC5378687 SCOPUS ID: 2-s2.0-85006289219 10/08/2016       38 Citations
  • Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. (Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M) Bone Marrow Transplant 2016 Dec;51(12):1602-1604 PMID: 27595288 SCOPUS ID: 2-s2.0-84991038636 09/07/2016       13 Citations
  • Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. (Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HSL, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD) Biol Blood Marrow Transplant 2016 Dec;22(12):2256-2263 PMID: 27565521 PMCID: PMC5116244 SCOPUS ID: 2-s2.0-84992110582 08/28/2016       22 Citations
  • Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft. (Epperla N, Pasquini M, Pierce K, Drobyski WR, Rizzo JD, Horowitz MM, Saber W, Zellner K, Ramirez S, Bartz K, Raj RV, Hari PN, Hamadani M) Bone Marrow Transplant 2017 Jan;52(1):147-150 PMID: 27479688 SCOPUS ID: 2-s2.0-84980370503 08/02/2016       5 Citations
  • Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. (Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE) Bone Marrow Transplant 2016 Sep;51(9):1173-9 PMID: 27159181 SCOPUS ID: 2-s2.0-84966474594 05/10/2016       34 Citations
  • Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study. (Denzen EM, Thao V, Hahn T, Lee SJ, McCarthy PL, Rizzo JD, Ammi M, Drexler R, Flesch S, James H, Omondi N, Murphy E, Pederson K, Majhail NS) Bone Marrow Transplant 2016 Sep;51(9):1233-40 PMID: 27088381 PMCID: PMC5014617 SCOPUS ID: 2-s2.0-84964331125 04/19/2016       30 Citations
  • Patient and provider preferences: Treatment summary and survivorship care plans after hematopoietic cell transplant. (Elizabeth A Murphy , Navneet S. Majhail , Kevin Scott Baker , Beatrice Abetti , Balkrishna N. Jahagirdar , Naynesh KamaniJ. Douglas Rizzo , Wael Saber , Lizette Salazar , Barry Schatz , Karen Leslie Syrjala , John R. Wingard , Ellen M Denzen) Journal of Clinical Oncology DOI: 10.1200/jco.2016.34.3_suppl.63 Journal of Clinical Oncology 34, no. 3_suppl (January 20, 2016) 63-63. 01/20/2016    
  • Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). (Wood WA, Le-Rademacher J, Syrjala KL, Jim H, Jacobsen PB, Knight JM, Abidi MH, Wingard JR, Majhail NS, Geller NL, Rizzo JD, Fei M, Wu J, Horowitz MM, Lee SJ) Cancer 2016 Jan 01;122(1):91-8 PMID: 26439325 PMCID: PMC4707096 SCOPUS ID: 2-s2.0-84947968582 10/07/2015       53 Citations
  • Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. (Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE) Bone Marrow Transplant 2016 Jan;51(1):83-8 PMID: 26367222 PMCID: PMC4570237 SCOPUS ID: 2-s2.0-84953366034 09/15/2015       26 Citations
  • Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients. (Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JM, Ma J, Cole SW) Clin Cancer Res 2016 Jan 01;22(1):69-78 PMID: 26286914 PMCID: PMC4703514 SCOPUS ID: 2-s2.0-84954345425 08/20/2015       62 Citations
  • Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study. (Knight JM, Szabo A, Zhao S, Lyness JM, Sahler OJ, Liesveld JL, Sander T, Rizzo JD, Hillard CJ, Moynihan JA) Neurobiol Stress 2015;2:44-50 PMID: 26114153 PMCID: PMC4476410 SCOPUS ID: 2-s2.0-84934762315 06/27/2015       10 Citations
  • Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation. (Cornell RF, Zhong X, Arce-Lara C, Atallah E, Blust L, Drobyski WR, Fenske TS, Pasquini MC, Rizzo JD, Saber W, Hari PN) Bone Marrow Transplant 2015 Jul;50(7):914-7 PMID: 25915809 SCOPUS ID: 2-s2.0-84934862607 04/29/2015       25 Citations
  • Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. (Graff TM, Singavi AK, Schmidt W, Eastwood D, Drobyski WR, Horowitz M, Palmer J, Pasquini M, Rizzo DJ, Saber W, Hari P, Fenske TS) Bone Marrow Transplant 2015 Jul;50(7):947-53 PMID: 25867651 PMCID: PMC4490016 SCOPUS ID: 2-s2.0-84934795677 04/14/2015       33 Citations
  • Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. (Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC) Biol Blood Marrow Transplant 2015 Aug;21(8):1479-87 PMID: 25862591 PMCID: PMC4512746 SCOPUS ID: 2-s2.0-84937713457 04/12/2015       160 Citations
  • National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery. (Majhail NS, Mau LW, Chitphakdithai P, Payton T, Eckrich M, Joffe S, Lee SJ, LeMaistre CF, LeRademacher J, Loberiza F, Logan B, Parsons SK, Repaczki-Jones R, Robinett P, Rizzo JD, Murphy E, Denzen EM) Biol Blood Marrow Transplant 2015 Jul;21(7):1308-14 PMID: 25840337 PMCID: PMC4466059 SCOPUS ID: 2-s2.0-84930571638 04/04/2015       39 Citations
  • Integration of hematopoietic cell transplantation outcomes data : Data standards are not enough (Renner R, Carlis J, Maiers M, Rizzo JD, O’Neill C, Horowitz M, Gee K, Confer D) Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 2015;9162:139-146 SCOPUS ID: 2-s2.0-84947233287 01/01/2015       2 Citations
  • Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. (Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M) Biol Blood Marrow Transplant 2015 Apr;21(4):688-95 PMID: 25543094 PMCID: PMC4359657 SCOPUS ID: 2-s2.0-84924284376 12/30/2014       14 Citations
  • Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors. (Kenzik K, Huang IC, Rizzo JD, Shenkman E, Wingard J) Support Care Cancer 2015 Mar;23(3):797-807 PMID: 25193598 PMCID: PMC4312505 SCOPUS ID: 2-s2.0-84922141798 09/07/2014       48 Citations
  • Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis. (Dhakal B, Strouse C, D'Souza A, Arce-Lara C, Esselman J, Eastwood D, Pasquini M, Saber W, Drobyski W, Rizzo JD, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2014 Dec;20(12):1926-31 PMID: 25111581 SCOPUS ID: 2-s2.0-84912142377 08/12/2014       23 Citations
  • HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. (Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M) N Engl J Med 2014 Jul 24;371(4):339-48 PMID: 25054717 PMCID: PMC5965695 SCOPUS ID: 2-s2.0-84904566576 07/24/2014       771 Citations
  • [Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]. (Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplantation Society of Australia and New Zeland (BMTSANZ), East Mediterrnean Blood and Marrow Transplantation Group (EMBMT), Sociedale Brasileira de Transplante de Medula Ossea (SBTMO)) Rinsho Ketsueki 2014 Jun;55(6):607-32 PMID: 24975331 SCOPUS ID: 2-s2.0-84906538926 07/01/2014       9 Citations
  • Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. (Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2014 Oct;20(10):1530-6 PMID: 24910380 PMCID: PMC4163109 SCOPUS ID: 2-s2.0-84912532936 06/10/2014       67 Citations
  • Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. (Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM) Bone Marrow Transplant 2014 Aug;49(8):1016-21 PMID: 24777183 SCOPUS ID: 2-s2.0-84905686615 04/30/2014       23 Citations
  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. (Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W) Blood 2014 Jun 05;123(23):3664-71 PMID: 24744269 PMCID: PMC4047501 SCOPUS ID: 2-s2.0-84905902438 04/20/2014       690 Citations
  • Clinical guide to fertility preservation in hematopoietic cell transplant recipients. (Joshi S, Savani BN, Chow EJ, Gilleece MH, Halter J, Jacobsohn DA, Pidala J, Quinn GP, Cahn JY, Jakubowski AA, Kamani NR, Lazarus HM, Rizzo JD, Schouten HC, Socie G, Stratton P, Sorror ML, Warwick AB, Wingard JR, Loren AW, Majhail NS) Bone Marrow Transplant 2014 Apr;49(4):477-84 PMID: 24419521 PMCID: PMC4071767 SCOPUS ID: 2-s2.0-84897553811 01/15/2014       87 Citations
  • Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. (Bredeson C, LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X, McCarthy PL, Ho VT, Cooke KR, Armstrong E, Smith A, Rizzo JD, Burkart JM, Pasquini MC) Blood 2013 Dec 05;122(24):3871-8 PMID: 24081656 PMCID: PMC3854109 SCOPUS ID: 2-s2.0-84887535514 10/02/2013       116 Citations
  • Screening and Prevention Guidelines for Hematopoietic Cell Transplant Survivors (Majhail NS, Rizzo JD) Blood and Marrow Transplantation Long Term Management: Prevention and Complications 9 September 2013:55-64 SCOPUS ID: 2-s2.0-85028290516 09/09/2013    
  • Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). (Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM) Blood 2013 Sep 12;122(11):1974-82 PMID: 23847196 PMCID: PMC3772501 SCOPUS ID: 2-s2.0-84887389178 07/13/2013       83 Citations
  • Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. (Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR) Biol Blood Marrow Transplant 2013 Sep;19(9):1368-73 PMID: 23806770 SCOPUS ID: 2-s2.0-84882809747 06/29/2013       27 Citations
  • Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. (Hahn T, McCarthy PL Jr, Hassebroek A, Bredeson C, Gajewski JL, Hale GA, Isola LM, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS) J Clin Oncol 2013 Jul 01;31(19):2437-49 PMID: 23715573 PMCID: PMC3691359 SCOPUS ID: 2-s2.0-84883105163 05/30/2013       204 Citations
  • Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. (McCarthy PL Jr, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G, Isola L, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS) Biol Blood Marrow Transplant 2013 Jul;19(7):1116-23 PMID: 23660172 PMCID: PMC3694566 SCOPUS ID: 2-s2.0-84879336748 05/11/2013       86 Citations
  • Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents. (Omondi NA, Ferguson SE, Majhail NS, Denzen EM, Buchanan GR, Haight AE, Labotka RJ, Rizzo JD, Murphy EA) J Pediatr Hematol Oncol 2013 May;35(4):289-98 PMID: 23612380 PMCID: PMC3659415 SCOPUS ID: 2-s2.0-84878650616 04/25/2013       28 Citations
  • Surviving the cure: long term followup of hematopoietic cell transplant recipients. (Majhail NS, Rizzo JD) Bone Marrow Transplant 2013 Sep;48(9):1145-51 PMID: 23292238 SCOPUS ID: 2-s2.0-84883743696 01/08/2013       110 Citations
  • Effects of spleen status on early outcomes after hematopoietic cell transplantation. (Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT) Bone Marrow Transplant 2013 Jun;48(6):825-31 PMID: 23222382 PMCID: PMC3606905 SCOPUS ID: 2-s2.0-84879072722 12/12/2012       56 Citations
  • Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. (Majhail NS, Rizzo JD, Hahn T, Lee SJ, McCarthy PL, Ammi M, Denzen E, Drexler R, Flesch S, James H, Omondi N, Pedersen TL, Murphy E, Pederson K) Bone Marrow Transplant 2013 Jun;48(6):865-71 PMID: 23222378 PMCID: PMC3596484 SCOPUS ID: 2-s2.0-84879094077 12/12/2012       46 Citations
  • Comprehensive stem cell transplant (SCT) outcome data submission. (Martinez C, Rizzo JD, Reeves D) J Clin Oncol 2012 Dec;30(34_suppl):293 PMID: 28147178 12/01/2012    
  • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. (Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Lint MT, Wingard JR, Tichelli A) Rev Bras Hematol Hemoter 2012;34(2):109-33 PMID: 23049402 PMCID: PMC3459383 SCOPUS ID: 2-s2.0-84861439006 10/11/2012       43 Citations
  • Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. (Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M) Biol Blood Marrow Transplant 2012 Nov;18(11):1727-33 PMID: 22766220 PMCID: PMC3472079 SCOPUS ID: 2-s2.0-84867505772 07/07/2012       115 Citations
  • First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. (Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR, Shaughnessy PJ, Wall DA, Carpenter PA) Biol Blood Marrow Transplant 2012 Aug;18(8):1150-63 PMID: 22510384 PMCID: PMC3404151 SCOPUS ID: 2-s2.0-84862137300 04/19/2012       458 Citations
  • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. (Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT), Sociedade Brasileira de Transplante de Medula Ossea (SBTMO)) Hematol Oncol Stem Cell Ther 2012;5(1):1-30 PMID: 22446607 PMCID: PMC3393086 SCOPUS ID: 2-s2.0-84859044853 03/27/2012       65 Citations
  • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. (Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research, American Society for Blood and Marrow Transplantation, European Group for Blood and Marrow Transplantation, Asia-Pacific Blood and Marrow Transplantation Group, Bone Marrow Transplant Society of Australia and New Zealand, East Mediterranean Blood and Marrow Transplantation Group, Sociedade Brasileira de Transplante de Medula Ossea) Bone Marrow Transplant 2012 Mar;47(3):337-41 PMID: 22395764 PMCID: PMC3393084 SCOPUS ID: 2-s2.0-84863242119 03/08/2012       185 Citations
  • Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. (Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J) Blood 2012 Apr 26;119(17):3908-16 PMID: 22327226 PMCID: PMC3350357 SCOPUS ID: 2-s2.0-84860342455 02/14/2012       208 Citations
  • Supportive care of hematopoietic cell transplant patients. (Jim HS, Syrjala KL, Rizzo D) Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S12-6 PMID: 22226095 PMCID: PMC3445407 SCOPUS ID: 2-s2.0-84855382957 01/18/2012       14 Citations
  • Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation. (Socié G, Rizzo JD) Semin Hematol 2012 Jan;49(1):4-9 PMID: 22221779 SCOPUS ID: 2-s2.0-84855409965 01/10/2012       25 Citations
  • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. (Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT),, Sociedade Brasileira de Transplante de Medula Ossea (SBTMO)) Biol Blood Marrow Transplant 2012 Mar;18(3):348-71 PMID: 22178693 PMCID: PMC3279570 SCOPUS ID: 2-s2.0-84863012690 12/20/2011       284 Citations
  • Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. (Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, Lazarus HM, LeMaistre CF, McCarthy P, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, Majhail NS) Biol Blood Marrow Transplant 2012 Jun;18(6):903-12 PMID: 22062801 PMCID: PMC3874400 SCOPUS ID: 2-s2.0-84860838979 11/09/2011       34 Citations
  • Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. (Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM) Biol Blood Marrow Transplant 2012 Jun;18(6):861-73 PMID: 22040843 PMCID: PMC3288160 SCOPUS ID: 2-s2.0-84860840686 11/02/2011       52 Citations
  • Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results. (Howard DH, Kenline C, Lazarus HM, Lemaistre CF, Maziarz RT, McCarthy PL Jr, Parsons SK, Szwajcer D, Douglas Rizzo J, Majhail NS) Health Serv Res 2011 Dec;46(6pt1):1762-77 PMID: 21790588 PMCID: PMC3393031 SCOPUS ID: 2-s2.0-81755184338 07/28/2011       25 Citations
  • Tocilizumab for the treatment of steroid refractory graft-versus-host disease. (Drobyski WR, Pasquini M, Kovatovic K, Palmer J, Douglas Rizzo J, Saad A, Saber W, Hari P) Biol Blood Marrow Transplant 2011 Dec;17(12):1862-8 PMID: 21745454 PMCID: PMC3716013 SCOPUS ID: 2-s2.0-81255163590 07/13/2011       95 Citations
  • Allogeneic transplant physician and center capacity in the United States. (Majhail NS, Murphy EA, Omondi NA, Robinett P, Gajewski JL, LeMaistre CF, Confer D, Rizzo JD) Biol Blood Marrow Transplant 2011 Jul;17(7):956-61 PMID: 21540121 PMCID: PMC3114271 SCOPUS ID: 2-s2.0-79958750601 05/05/2011       42 Citations
  • Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. (Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G) J Clin Oncol 2011 Jun 01;29(16):2230-9 PMID: 21464398 PMCID: PMC3107742 SCOPUS ID: 2-s2.0-79957958325 04/06/2011       503 Citations
  • American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S) J Oncol Pract 2010 Nov;6(6):317-20 PMID: 21358963 PMCID: PMC2988667 SCOPUS ID: 2-s2.0-79952380217 03/02/2011       38 Citations
  • Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? (Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC) J Clin Oncol 2011 Mar 01;29(7):805-13 PMID: 21220593 PMCID: PMC3068057 SCOPUS ID: 2-s2.0-79952356420 01/12/2011       160 Citations
  • Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. (Turbeville S, Nicely H, Rizzo JD, Pedersen TL, Orchard PJ, Horwitz ME, Horwitz EM, Veys P, Bonfim C, Al-Seraihy A) Mol Genet Metab 2011 Feb;102(2):111-5 PMID: 20980181 PMCID: PMC3367500 SCOPUS ID: 2-s2.0-78651426962 10/29/2010       59 Citations
  • American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Clinical Oncology, American Society of Hematology) J Clin Oncol 2010 Nov 20;28(33):4996-5010 PMID: 20975064 SCOPUS ID: 2-s2.0-78651434523 10/27/2010       230 Citations
  • American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee) Blood 2010 Nov 18;116(20):4045-59 PMID: 20974674 SCOPUS ID: 2-s2.0-78549286047 10/27/2010       179 Citations
  • Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. (Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G) Blood 2011 Jan 06;117(1):316-22 PMID: 20926773 PMCID: PMC3037753 SCOPUS ID: 2-s2.0-78650988748 10/12/2010       166 Citations
  • Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. (Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC, Regimen-Related Toxicity Writing Committee, Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2011 May;17(5):737-44 PMID: 20817111 PMCID: PMC3035737 SCOPUS ID: 2-s2.0-79954570682 09/08/2010       25 Citations
  • Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. (Wingard JR, Huang IC, Sobocinski KA, Andrykowski MA, Cella D, Rizzo JD, Brady M, Horowitz MM, Bishop MM) Biol Blood Marrow Transplant 2010 Dec;16(12):1682-92 PMID: 20685400 PMCID: PMC2975785 SCOPUS ID: 2-s2.0-78149407957 08/06/2010       35 Citations
  • Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). (Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socié G, Wingard JR, Rizzo JD, Majhail NS) Biol Blood Marrow Transplant 2011 Feb;17(2):157-66 PMID: 20659574 PMCID: PMC3017731 SCOPUS ID: 2-s2.0-79151484630 07/28/2010       83 Citations
  • Access to hematopoietic stem cell transplantation: effect of race and sex. (Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM) Cancer 2010 Jul 15;116(14):3469-76 PMID: 20564154 PMCID: PMC3153958 SCOPUS ID: 2-s2.0-77954889709 06/22/2010       115 Citations
  • High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. (Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD) Bone Marrow Transplant 2011 Mar;46(3):385-92 PMID: 20479710 PMCID: PMC2978251 SCOPUS ID: 2-s2.0-79952532602 05/19/2010       23 Citations
  • Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. (Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD) Biol Blood Marrow Transplant 2010 Oct;16(10):1442-50 PMID: 20412867 PMCID: PMC2933950 SCOPUS ID: 2-s2.0-77956270036 04/24/2010       61 Citations
  • Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia. (Uberti JP, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman C, McCarthy PL, Ratanatharathorn V, Ringdén O, Weisdorf DJ, Rizzo JD) Bone Marrow Transplant 2011 Jan;46(1):34-43 PMID: 20400989 PMCID: PMC3169009 SCOPUS ID: 2-s2.0-78651346532 04/20/2010       21 Citations
  • Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States. (O'Donnell PV, Pedersen TL, Confer DL, Rizzo JD, Pulsipher MA, Stroncek D, Leitman S, Anderlini P, Donor Health and Safety Working Committee from Center for International Blood and Marrow Transplant Research (CIBMTR)) Blood 2010 Jun 17;115(24):5097-101 PMID: 20228276 PMCID: PMC2890146 SCOPUS ID: 2-s2.0-77954716687 03/17/2010       48 Citations
  • Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. (Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD) J Clin Oncol 2010 Apr 10;28(11):1888-95 PMID: 20212247 PMCID: PMC2860369 SCOPUS ID: 2-s2.0-77951632041 03/10/2010       104 Citations
  • Second unrelated donor hematopoietic cell transplantation for primary graft failure. (Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC) Biol Blood Marrow Transplant 2010 Aug;16(8):1099-106 PMID: 20172038 PMCID: PMC2897953 SCOPUS ID: 2-s2.0-77954316434 02/23/2010       68 Citations
  • Can a modest exercise program really improve physical functioning and quality of life among recipients of hematopoietic SCT? (Somerfield MR, Rizzo JD) Bone Marrow Transplant 2010 Feb;45(2):217-8 PMID: 20145625 SCOPUS ID: 2-s2.0-76749157171 02/11/2010       6 Citations
  • The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation. (Murphy EA, Ferguson SS, Omondi NA, Getzendaner LC, Gajewski JL, Goldstein GA, Wingard JR, Rizzo JD, Majhail NS) Biol Blood Marrow Transplant 2010 Feb;16(2):147-56 PMID: 20142045 SCOPUS ID: 2-s2.0-75149151795 02/10/2010       13 Citations
  • A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. (Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Hari PN) Biol Blood Marrow Transplant 2010 Jan;16(1):35-45 PMID: 20053330 PMCID: PMC2929576 SCOPUS ID: 2-s2.0-72649090031 01/08/2010       75 Citations
  • Access to hematopoietic cell transplantation in the United States. (Majhail NS, Omondi NA, Denzen E, Murphy EA, Rizzo JD) Biol Blood Marrow Transplant 2010 Aug;16(8):1070-5 PMID: 20036337 PMCID: PMC3144674 SCOPUS ID: 2-s2.0-77954311007 12/29/2009       79 Citations
  • Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. (Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ) Blood 2010 Mar 04;115(9):1850-7 PMID: 20032503 PMCID: PMC2832815 SCOPUS ID: 2-s2.0-77950361766 12/25/2009       185 Citations
  • Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. (Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O'Reilly RJ, Rizzo JD, Roifman CM, Small TN, Shearer WT, Workshop Participants) J Allergy Clin Immunol 2009 Dec;124(6):1152-60.e12 PMID: 20004776 PMCID: PMC2831471 SCOPUS ID: 2-s2.0-71149121906 12/17/2009       105 Citations
  • Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. (Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, LeMaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P) Biol Blood Marrow Transplant 2010 Mar;16(3):395-402 PMID: 19922808 PMCID: PMC2833344 SCOPUS ID: 2-s2.0-75749106529 11/20/2009       49 Citations
  • Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. (Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C, Dehn J, Friedman D, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Loberiza F, Maharaj D, McCarthy P, Setterholm M, Spellman S, Trigg M, Maziarz RT, Switzer G, Lee SJ, Rizzo JD) Biol Blood Marrow Transplant 2009 Dec;15(12):1543-54 PMID: 19896078 PMCID: PMC2775819 SCOPUS ID: 2-s2.0-70350774049 11/10/2009       124 Citations
  • Defining the intensity of conditioning regimens: working definitions. (Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M) Biol Blood Marrow Transplant 2009 Dec;15(12):1628-33 PMID: 19896087 PMCID: PMC2861656 SCOPUS ID: 2-s2.0-70350764819 11/10/2009       1311 Citations
  • Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence. (Loberiza FR Jr, Lee SJ, Klein JP, Hassebroek A, Dehn JG, Frangoul HA, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Maziarz RT, Rizzo JD, Majhail NS) Biol Blood Marrow Transplant 2010 Mar;16(3):368-75 PMID: 19879951 PMCID: PMC2822013 SCOPUS ID: 2-s2.0-75749146165 11/03/2009       26 Citations
  • Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. (Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM) Biol Blood Marrow Transplant 2009 Nov;15(11):1455-64 PMID: 19822306 PMCID: PMC2913553 SCOPUS ID: 2-s2.0-70350587347 10/14/2009       49 Citations
  • Impending challenges in the hematopoietic stem cell transplantation physician workforce. (Gajewski JL, LeMaistre CF, Silver SM, Lill MC, Selby GB, Horowitz MM, Rizzo JD, Heslop HE, Anasetti C, Maziarz RT) Biol Blood Marrow Transplant 2009 Dec;15(12):1493-501 PMID: 19781658 SCOPUS ID: 2-s2.0-70350475710 09/29/2009       42 Citations
  • The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. (Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA, Wingard JR) Biol Blood Marrow Transplant 2010 Feb;16(2):207-14 PMID: 19781657 PMCID: PMC2819641 SCOPUS ID: 2-s2.0-75149132436 09/29/2009       58 Citations
  • The effect of smoking on allogeneic transplant outcomes. (Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy PL, Ringdén O, Schouten HC, Seftel M, Rizzo JD) Biol Blood Marrow Transplant 2009 Oct;15(10):1277-87 PMID: 19747636 PMCID: PMC2768519 SCOPUS ID: 2-s2.0-69749091932 09/15/2009       23 Citations
  • Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation. (Loberiza FR Jr, Lee SJ, Freytes CO, Giralt SA, Van Besien K, Kurian S, del Cerro P, Toro JJ, Williams LA, Ketelsen SW, Navarro WH, Rizzo JD) Biol Blood Marrow Transplant 2009 Aug;15(8):903-9 PMID: 19589479 PMCID: PMC2911964 SCOPUS ID: 2-s2.0-67649619560 07/11/2009       4 Citations
  • Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. (Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD) Br J Haematol 2009 Oct;147(1):129-39 PMID: 19573079 PMCID: PMC2748179 SCOPUS ID: 2-s2.0-70349207133 07/04/2009       53 Citations
  • Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation. (Jones RB, Nieto Y, Wall D, Wingard JR, Rizzo JD, McCarthy PL Jr, Oliansky D, Hahn T, ASBMT Steering Committee on Evidence-Based Reviews) Biol Blood Marrow Transplant 2009 Jun;15(6):761-2 PMID: 19450763 SCOPUS ID: 2-s2.0-67349151914 05/20/2009       7 Citations
  • Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. (Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE) Blood 2009 May 14;113(20):4992-5001 PMID: 19264919 PMCID: PMC2686146 SCOPUS ID: 2-s2.0-66549099010 03/07/2009       333 Citations
  • Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. (Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B) Biol Blood Marrow Transplant 2009 Mar;15(3):367-9 PMID: 19203728 PMCID: PMC3110087 SCOPUS ID: 2-s2.0-59349093509 02/11/2009       663 Citations
  • Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL) Blood 2009 Apr 09;113(15):3604-11 PMID: 19190248 PMCID: PMC2668845 SCOPUS ID: 2-s2.0-65349145905 02/05/2009       209 Citations
  • Response: Solid cancers after allogeneic hematopoietic cell transplantation (Rizzo JD, Curtis RE, Deeg HJ, Travis LB) Blood 2009;114(1):225-226 SCOPUS ID: 2-s2.0-70449348140 01/01/2009       1 Citation
  • Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). (Lazarus HM, Carreras J, Boudreau C, Loberiza FR Jr, Armitage JO, Bolwell BJ, Freytes CO, Gale RP, Gibson J, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Marks DI, Miller AM, Pavlovsky S, Schouten HC, van Besien K, Vose JM, Bitran JD, Khouri IF, McCarthy PL, Yu H, Rowlings P, Serna DS, Horowitz MM, Rizzo JD, Center For International Blood & Marrow Transplant Research (CIBMTR)) Biol Blood Marrow Transplant 2008 Dec;14(12):1323-33 PMID: 19041053 PMCID: PMC2638759 SCOPUS ID: 2-s2.0-56749184062 12/02/2008       35 Citations
  • Solid cancers after allogeneic hematopoietic cell transplantation. (Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ) Blood 2009 Jan 29;113(5):1175-83 PMID: 18971419 PMCID: PMC2635083 SCOPUS ID: 2-s2.0-60849115555 10/31/2008       387 Citations
  • In reply (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Miller CB, Rarick MU, Regan DH, Lichtin AE) Journal of Clinical Oncology 2008;26(18):3098-3100 SCOPUS ID: 2-s2.0-51349083662 09/15/2008    
  • Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. (Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, Brown C, Chaudhry MA, Horowitz MM, Kurian S, Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, Stewart DA) Biol Blood Marrow Transplant 2008 Sep;14(9):993-1003 PMID: 18721762 PMCID: PMC3321981 SCOPUS ID: 2-s2.0-49649102973 08/30/2008       75 Citations
  • Allogeneic hematopoietic cell transplantation for metastatic breast cancer. (Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM, Champlin RE, Stiff PJ, Niederwieser D) Bone Marrow Transplant 2008 Mar;41(6):537-45 PMID: 18084340 SCOPUS ID: 2-s2.0-41549095493 12/18/2007       42 Citations
  • Are there circumstances in which phase 2 study results should be practice-changing? (Tomblyn MR, Rizzo JD) Hematology Am Soc Hematol Educ Program 2007:489-92 PMID: 18024669 SCOPUS ID: 2-s2.0-67650267370 11/21/2007       14 Citations
  • Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE) Blood 2008 Jan 01;111(1):25-41 PMID: 17954703 SCOPUS ID: 2-s2.0-38049174952 10/24/2007       144 Citations
  • Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE, American Society of Clinical Oncology, American Society of Hematology) J Clin Oncol 2008 Jan 01;26(1):132-49 PMID: 17954713 SCOPUS ID: 2-s2.0-37849003198 10/24/2007       259 Citations
  • Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. (Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD) Biol Blood Marrow Transplant 2007 Jul;13(7):778-89 PMID: 17580256 SCOPUS ID: 2-s2.0-34250208443 06/21/2007       10 Citations
  • Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. (Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D) Biol Blood Marrow Transplant 2007 Jul;13(7):844-52 PMID: 17580263 SCOPUS ID: 2-s2.0-34250192560 06/21/2007       63 Citations
  • Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. (Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR) J Clin Oncol 2007 Apr 10;25(11):1403-11 PMID: 17416860 SCOPUS ID: 2-s2.0-34248166981 04/10/2007       167 Citations
  • The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. (Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO 3rd, Wilmot F, McCarthy PL Jr, Hahn T) Biol Blood Marrow Transplant 2007 Jan;13(1):1-25 PMID: 17222748 SCOPUS ID: 2-s2.0-33846057947 01/16/2007       64 Citations
  • Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE, International Bone Marrow Transplant Registry, European Group for Blood and Marrow Transplantation) Blood 2006 Dec 15;108(13):4288-90 PMID: 16946302 PMCID: PMC1895450 SCOPUS ID: 2-s2.0-33845478320 09/02/2006       145 Citations
  • Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. (Navarro WH, Loberiza FR Jr, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, Rizzo JD) Biol Blood Marrow Transplant 2006 May;12(5):541-51 PMID: 16635789 SCOPUS ID: 2-s2.0-33745461684 04/26/2006       74 Citations
  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. (Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD, Foley R, Socie G, Carter S, Couriel D, Schultz KR, Flowers ME, Filipovich AH, Saliba R, Vogelsang GB, Pavletic SZ, Lee SJ, Design of Clinical Trials Working Group) Biol Blood Marrow Transplant 2006 May;12(5):491-505 PMID: 16635784 SCOPUS ID: 2-s2.0-33745447476 04/26/2006       153 Citations
  • Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. (Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, Zhang MJ, Horowitz MM) Br J Haematol 2006 Mar;132(6):755-69 PMID: 16487177 SCOPUS ID: 2-s2.0-33644900481 02/21/2006       55 Citations
  • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. (Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socié G) Biol Blood Marrow Transplant 2006 Feb;12(2):138-51 PMID: 16443512 SCOPUS ID: 2-s2.0-31344451655 01/31/2006       229 Citations
  • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). (Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socié G) Bone Marrow Transplant 2006 Feb;37(3):249-61 PMID: 16435004 SCOPUS ID: 2-s2.0-33645302973 01/26/2006       101 Citations
  • Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities. (Schwake CJ, Eapen M, Lee SJ, Freytes CO, Giralt SA, Navarro WH, Rizzo JD, van Besien K, Loberiza FR Jr) Biol Blood Marrow Transplant 2005 Dec;11(12):988-98 PMID: 16338621 SCOPUS ID: 2-s2.0-28744450153 12/13/2005       11 Citations
  • National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. (Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME) Biol Blood Marrow Transplant 2005 Dec;11(12):945-56 PMID: 16338616 SCOPUS ID: 2-s2.0-28744444180 12/13/2005       3017 Citations
  • The evolution of the evidence-based review: evaluating the science enhances the art of medicine--statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation. (Jones R, Nieto Y, Rizzo JD, Wall D, Wingard JR, McCarthy P Jr, Hahn T, Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation) Biol Blood Marrow Transplant 2005 Nov;11(11):819-22 PMID: 16275587 SCOPUS ID: 2-s2.0-27844445284 11/09/2005       18 Citations
  • Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. (Santo Tomas LH, Loberiza FR Jr, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, Bredeson CN, Horowitz MM) Chest 2005 Jul;128(1):153-61 PMID: 16002929 SCOPUS ID: 2-s2.0-22244447765 07/09/2005       144 Citations
  • A case of retroperitoneal fibrosis in a patient following HSCT. (Nanda A, Rizzo JD, Vogelsang GB) Bone Marrow Transplant 2005 Jun;35(11):1125-6 PMID: 15821767 SCOPUS ID: 2-s2.0-20044373910 04/12/2005       2 Citations
  • Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy? (Rizzo JD) Best Pract Res Clin Haematol 2005;18(3):439-48 PMID: 15792918 SCOPUS ID: 2-s2.0-15844393902 03/29/2005       2 Citations
  • Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. (Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ) Blood 2005 May 15;105(10):3802-11 PMID: 15687239 PMCID: PMC1895092 SCOPUS ID: 2-s2.0-20844439888 02/03/2005       263 Citations
  • Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. (Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR) J Clin Oncol 2005 Jan 20;23(3):599-608 PMID: 15659507 SCOPUS ID: 2-s2.0-20044367440 01/22/2005       262 Citations
  • Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. (Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD) Blood 2005 Apr 01;105(7):2979-87 PMID: 15598815 SCOPUS ID: 2-s2.0-20144389335 12/16/2004       77 Citations
  • Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. (Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K, Lymphoma Working Committee of the International Bone Marrow Transplant Registry) Blood 2004 Dec 01;104(12):3797-803 PMID: 15280203 SCOPUS ID: 2-s2.0-9444272217 07/29/2004       103 Citations
  • Patient and transplant center factors associated with 100D mortality after receiving allogeneic hematopoietic stem cell transplantation (HSCT). (Loberiza FR, Zhang M, Rizzo JD, Lee SJ, Klein JP, Logan BR, Eapen M, Serna DS, Lemaistre CF, Horowitz MM) J Clin Oncol 2004 Jul 15;22(14_suppl):6026 PMID: 28015094 07/15/2004    
  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. (Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM) Blood 2004 Jul 15;104(2):579-85 PMID: 15039286 SCOPUS ID: 2-s2.0-3142580475 03/25/2004       579 Citations
  • Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. (Vose JM, Rizzo DJ, Tao-Wu J, Armitage JO, Bashey A, Burns LJ, Christiansen NP, Freytes CO, Gale RP, Gibson J, Giralt SA, Herzig RH, Lemaistre CF, McCarthy PL Jr, Nimer SD, Petersen FB, Schenkein DP, Wiernik PH, Wiley JM, Loberiza FR, Lazarus HM, van Biesen K, Horowitz MM) Biol Blood Marrow Transplant 2004 Feb;10(2):116-27 PMID: 14750077 SCOPUS ID: 2-s2.0-0742323747 01/30/2004       47 Citations
  • Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. (Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr) J Clin Oncol 2003 Oct 15;21(20):3754-60 PMID: 14551294 SCOPUS ID: 2-s2.0-0142023889 10/11/2003       72 Citations
  • Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A, Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation) J Clin Oncol 2003 Oct 15;21(20):3744-53 PMID: 12963703 SCOPUS ID: 2-s2.0-0142023893 09/10/2003       136 Citations
  • Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. (van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora AL, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM) Blood 2003 Nov 15;102(10):3521-9 PMID: 12893748 SCOPUS ID: 2-s2.0-0242411675 08/02/2003       313 Citations
  • Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. (Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH) Bone Marrow Transplant 2003 Jul;32(2):151-5 PMID: 12838279 SCOPUS ID: 2-s2.0-10744226696 07/03/2003       4 Citations
  • Optimistic expectations and survival after hematopoietic stem cell transplantation. (Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC) Biol Blood Marrow Transplant 2003 Jun;9(6):389-96 PMID: 12813447 SCOPUS ID: 2-s2.0-1542787244 06/19/2003       49 Citations
  • Subcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplant. (Rosenblum MD, Bredeson CN, Chang CC, Rizzo JD) Am J Hematol 2003 Apr;72(4):274-7 PMID: 12666140 SCOPUS ID: 2-s2.0-0037380242 04/01/2003       34 Citations
  • Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? (Loberiza FR Jr, Serna DS, Horowitz MM, Rizzo JD) Bone Marrow Transplant 2003 Mar;31(6):417-21 PMID: 12665834 SCOPUS ID: 2-s2.0-0037366808 04/01/2003       30 Citations
  • Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. (Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N) Br J Haematol 2003 Mar;120(5):793-800 PMID: 12614212 SCOPUS ID: 2-s2.0-0037336639 03/05/2003       145 Citations
  • A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. (Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ, Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry) Blood 2003 Apr 01;101(7):2476-82 PMID: 12456505 SCOPUS ID: 2-s2.0-0038446692 11/29/2002       132 Citations
  • Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. (Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ) Blood 2003 Mar 01;101(5):2015-23 PMID: 12393427 SCOPUS ID: 2-s2.0-0037370887 10/24/2002       178 Citations
  • Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology. American Society of Hematology) J Clin Oncol 2002 Oct 01;20(19):4083-107 PMID: 12351606 SCOPUS ID: 2-s2.0-0036787775 09/28/2002       402 Citations
  • Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology, Americcan Society of Hematology) Blood 2002 Oct 01;100(7):2303-20 PMID: 12239138 SCOPUS ID: 2-s2.0-0036786902 09/20/2002       204 Citations
  • Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. (Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM) Blood 2002 Sep 15;100(6):1997-2004 PMID: 12200358 SCOPUS ID: 2-s2.0-0037105374 08/30/2002       246 Citations
  • Autologous stem cell transplantation for small cell lung cancer. (Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM) Biol Blood Marrow Transplant 2002;8(5):273-80 PMID: 12064365 SCOPUS ID: 2-s2.0-0036276301 06/18/2002       14 Citations
  • Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. (Loberiza FR Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ) J Clin Oncol 2002 Apr 15;20(8):2118-26 PMID: 11956273 SCOPUS ID: 2-s2.0-0037089593 04/17/2002       181 Citations
  • Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. (Klein JP, Rizzo JD, Zhang MJ, Keiding N) Bone Marrow Transplant 2001 Dec;28(11):1001-11 PMID: 11781608 SCOPUS ID: 2-s2.0-0035663624 01/10/2002       173 Citations
  • Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. (Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR) Biol Blood Marrow Transplant 2001;7(11):620-30 PMID: 11760150 SCOPUS ID: 2-s2.0-0034747266 01/05/2002       57 Citations
  • Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. (Klein JP, Rizzo JD, Zhang MJ, Keiding N) Bone Marrow Transplant 2001 Nov;28(10):909-15 PMID: 11753543 SCOPUS ID: 2-s2.0-0035203456 12/26/2001       205 Citations
  • Erythropoietin: a paradigm for the development of practice guidelines. (Rizzo JD, Seidenfeld J, Piper M, Aronson N, Lichtin A, Littlewood TJ) Hematology Am Soc Hematol Educ Program 2001:10-30 PMID: 11722976 SCOPUS ID: 2-s2.0-0035231518 11/28/2001       35 Citations
  • Transplant registries: guiding clinical decisions and improving outcomes. (Horowitz MM, Loberiza FR, Bredeson CN, Rizzo JD, Nugent ML) Oncology (Williston Park) 2001 May;15(5):649-59; discussion 663-4, 666 PMID: 11396358 SCOPUS ID: 2-s2.0-0035351024 06/09/2001       29 Citations
  • Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. (Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM, IBMTR Statistical Center of the International Bone Marrow Transplant Registry, Medical College of Wisconcin, Milwaukee, WI, USA, EBMT, Kiel, Germany) Bone Marrow Transplant 2001 Apr;27(7):689-92 PMID: 11360107 SCOPUS ID: 2-s2.0-0035037982 05/22/2001       115 Citations
  • Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). (Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM) Bone Marrow Transplant 2001 Feb;27(4):387-96 PMID: 11313668 SCOPUS ID: 2-s2.0-17744384690 04/21/2001       110 Citations
  • Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? (Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB) J Clin Oncol 1999 Sep;17(9):2811-8 PMID: 10561357 SCOPUS ID: 2-s2.0-0032878585 11/24/1999       68 Citations
  • Methodological hurdles in conducting pharmacoeconomic analyses. (Rizzo JD, Powe NR) Pharmacoeconomics 1999 Apr;15(4):339-55 PMID: 10537953 SCOPUS ID: 2-s2.0-0032929416 10/28/1999       19 Citations
  • Replacement of central vascular catheters. (Rizzo JD, Strom BL, Berlin J) N Engl J Med 1993 Feb 11;328(6):445-6 PMID: 8421471 SCOPUS ID: 2-s2.0-0027389252 02/11/1993       3 Citations
  • Expression of vimentin by rabbit corneal epithelial cells during wound repair. (SundarRaj N, Rizzo JD, Anderson SC, Gesiotto JP) Cell Tissue Res 1992 Feb;267(2):347-56 PMID: 1376216 SCOPUS ID: 2-s2.0-0026598869 02/01/1992       55 Citations
  • A simple technique for determining relative toxicities of Bacillus thuringiensis var. Israelensis formulations against larval blackflies (Diptera: Simuliidae). (Barton WE, Noblet R, Kurtak DC) J Am Mosq Control Assoc 1991 Jun;7(2):313-5 PMID: 1895092 SCOPUS ID: 2-s2.0-0026179360 06/01/1991       7 Citations
  • Meningism in a ten-month-old infant during OKT3 therapy. (Rizzo JD, Rowe SA) J Heart Transplant 1990;9(6):727-8 PMID: 2126036 SCOPUS ID: 2-s2.0-0025520820 11/01/1990       2 Citations
  • Uranium assay in milk and drug samples using solid-state track detectors. (Bansal V, Azam A, Prasad R) Health Phys 1989 Dec;57(6):985-7 PMID: 2584033 SCOPUS ID: 2-s2.0-0024778431 12/01/1989       6 Citations
    • Last update: 01/17/2024